Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Circuport
AddedFeb 18, 2024
UpdatedJun 18, 2026
Circuport

Circuport

Acquired

Circuport, Inc.: Providing innovative vascular access systems for hemodialysis patients since 2006.

HQ
Morristown, NJ, US
Founded
2006
Overview
Compare
Fundraising
Employees

Circuport, Inc. provides innovative vascular access systems for hemodialysis patients. Their flagship product, the Circuport System, includes an implantable port and a frame to prevent vessel compression during needle access. The company, founded in 2006, is based in Morristown, New Jersey.

Circuport has significantly impacted the hemodialysis market by improving patient outcomes and access efficiency. Their advancements in vascular access technology have set new standards in the industry, benefiting countless patients and healthcare providers.

Circuport - Similar Companies

Bioconnect Systems logo

Bioconnect Systems

Versago Vascular Access logo

Versago Vascular Access

Hemova Medical logo

Hemova Medical

Phraxis logo

Phraxis

phraxis.com

Avenu Medical logo

Avenu Medical

avenumedical.com

Stealth Therapeutics logo

Stealth Therapeutics

Access Vascular logo

Access Vascular

CircumFix Solutions logo

CircumFix Solutions

Bluegrass Vascular Technologies logo

Bluegrass Vascular Technologies

Voyager Biomedical logo

Voyager Biomedical

Cross Vascular logo

Cross Vascular

MicroPort Scientific logo

MicroPort Scientific

Venova Medical logo

Venova Medical

venovamed.com

Solinas Medical logo

Solinas Medical

solinasmedical.com

Vital Access logo

Vital Access

vital-access.com

Circuport - Quick Facts

Who are Circuport's competitors?

Companies similar to Circuport include Bioconnect Systems, Versago Vascular Access, Hemova Medical and Phraxis.

When was Circuport founded?

Circuport was founded in 2006.

Where is Circuport's headquarters located?

Circuport's headquarters is located in Morristown, NJ, US.

When was Circuport's last funding round?

Circuport's most recent funding round was for $800k (USD) in June 2010.

How much has Circuport raised to-date?

As of Jun 9, 2010, Circuport has raised a total of $800k (USD).

Circuport - Classification

Ownership
  • Private
Technology
  • HealthTech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Hardware
  • Medical
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
Show 13 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research